While we show that SRRM4 overexpression inhibits cell proliferation in all cancer cell lines tested (including the prostate cancer cell line DU145), in our experiments, SRRM4 did not induce SOX2 expression, which could explain the apparent contradiction. The gene discussed is SOX2; the disease is cancer.